Could GLP-1 receptor agonists treat addiction and dementia?
Drug Discovery World
AUGUST 21, 2023
Medications containing semaglutide such as Ozempic, licensed for diabetes, and Wegovy, for weight loss, are being studied to see if they can treat a range of different conditions, including addiction and dementia. GLP-1 is a hormone that is produced naturally in the brain and the gut in response to food ingestion.
Let's personalize your content